Literature DB >> 8227349

Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction.

Y Terada1, K Tomita, H Nonoguchi, T Yang, F Marumo.   

Abstract

Recent studies have revealed that arginine vasopressin (AVP) has at least two types of receptors in the kidney: V1a receptor and V2 receptor. In this study, microlocalization of mRNA coding for V1a and V2 receptors was carried out in the rat kidney using a reverse transcription and polymerase chain reaction. Large signals for V1a receptor PCR product were detected in the glomerulus, initial cortical collecting duct, cortical collecting duct, outer medullary collecting duct, inner medullary collecting duct, and arcuate artery. Small but detectable signals were found in proximal convoluted and straight tubules, inner medullary thin limbs, and medullary thick ascending limbs. Large signals for V2 receptor mRNA were detected in the cortical collecting duct, outer medullary collecting duct, and inner medullary collecting duct. Small signals for V2 receptor were found in the inner medullary thick limbs, medullary thick ascending limbs, and initial cortical collecting duct. Next, we investigated V1a and V2 receptor mRNA regulation in the dehydrated state. During a 72-h water restriction state, the plasma AVP level increased and V2 receptor mRNA decreased in collecting ducts. In contrast, V1a receptor mRNA did not change significantly. Thus, the two AVP receptor subtypes are distributed differently along the nephron, and these mRNAs are regulated differently in the dehydrated state.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227349      PMCID: PMC288415          DOI: 10.1172/JCI116838

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

Review 1.  Hormonal regulation of peptide receptors and target cell responses.

Authors:  K J Catt; J P Harwood; G Aguilera; M L Dufau
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

2.  Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin.

Authors:  R H Michell; C J Kirk; M M Billah
Journal:  Biochem Soc Trans       Date:  1979-10       Impact factor: 5.407

3.  Adenylate cyclase responsiveness to hormones in various portions of the human nephron.

Authors:  D Chabardès; M Gagnan-Brunette; M Imbert-Teboul; O Gontcharevskaia; M Montégut; A Clique; F Morel
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

4.  Stimulation of adenylate cyclase in isolated rat glomeruli by prostaglandins.

Authors:  D Schlondorff; P Yoo; B E Alpert
Journal:  Am J Physiol       Date:  1978-11

Review 5.  Sites of hormone action in the mammalian nephron.

Authors:  F Morel
Journal:  Am J Physiol       Date:  1981-03

Review 6.  The effects of antidiuretic hormone (ADH) on solute and water transport in the mammalian nephron.

Authors:  S C Hebert; J A Schafer; T E Andreoli
Journal:  J Membr Biol       Date:  1981-01-30       Impact factor: 1.843

7.  Vasopressin and oxytocin receptors coupled to Ca2+ mobilization in rat inner medullary collecting duct.

Authors:  Y Maeda; J S Han; C C Gibson; M A Knepper
Journal:  Am J Physiol       Date:  1993-07

8.  Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain.

Authors:  N L Ostrowski; S J Lolait; D J Bradley; A M O'Carroll; M J Brownstein; W S Young
Journal:  Endocrinology       Date:  1992-07       Impact factor: 4.736

9.  Desensitization of the human V2 vasopressin receptor. Homologous effects in the absence of heterologous desensitization.

Authors:  M Birnbaumer; A Antaramian; A P Themmen; S Gilbert
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  16 in total

Review 1.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  Rat renal arcade segment expresses vasopressin-regulated water channel and vasopressin V2 receptor.

Authors:  B K Kishore; B Mandon; N B Oza; S R DiGiovanni; R A Coleman; N L Ostrowski; J B Wade; M A Knepper
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

Review 4.  Vasopressin: a novel target for the prevention and retardation of kidney disease?

Authors:  Lise Bankir; Nadine Bouby; Eberhard Ritz
Journal:  Nat Rev Nephrol       Date:  2013-02-26       Impact factor: 28.314

5.  Molecular analysis of vasopressin receptors in the rat nephron. Evidence for alternative splicing of the V2 receptor.

Authors:  D Firsov; B Mandon; A Morel; J Merot; S Le Maout; A C Bellanger; C de Rouffignac; J M Elalouf; J M Buhler
Journal:  Pflugers Arch       Date:  1994-11       Impact factor: 3.657

6.  Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study.

Authors:  Belen Ponte; Menno Pruijm; Daniel Ackermann; Philippe Vuistiner; Idris Guessous; Georg Ehret; Heba Alwan; Sonia Youhanna; Fred Paccaud; Markus Mohaupt; Antoinette Péchère-Bertschi; Bruno Vogt; Michel Burnier; Pierre-Yves Martin; Olivier Devuyst; Murielle Bochud
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

7.  Effects of the renal medullary pH and ionic environment on vasopressin binding and signaling.

Authors:  Elena A Zalyapin; Richard Bouley; Udo Hasler; Jean-Pierre Vilardaga; Herbert Y Lin; Dennis Brown; Dennis A Ausiello
Journal:  Kidney Int       Date:  2008-08-27       Impact factor: 10.612

8.  Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.

Authors:  Tadashi Okada; Toshifumi Sakaguchi; Ikuji Hatamura; Fumie Saji; Shigeo Negi; Haruhisa Otani; Yasuteru Muragaki; Hiroshi Kawachi; Takashi Shigematsu
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

9.  Vasopressin resistance in chronic renal failure. Evidence for the role of decreased V2 receptor mRNA.

Authors:  I Teitelbaum; S McGuinness
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 10.  Lithium: a versatile tool for understanding renal physiology.

Authors:  Bellamkonda K Kishore; Carolyn M Ecelbarger
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.